Related Experiment Video
Updated: Aug 15, 2026
Genetic Manipulation of Cerebellar Granule Neurons In Vitro and In Vivo to Study Neuronal Morphology and Migration
Published on: March 17, 2014
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, Tennessee 38105, USA.
Abstract:
Somatic inactivation of PTEN occurs in different human tumors including glioblastoma, endometrial carcinoma and prostate carcinoma. Germline mutations in PTEN result in a range of phenotypic abnormalities that occur with variable penetrance, including neurological features such as macrocephaly, seizures, ataxia and Lhermitte-Duclos disease (also described as dysplastic gangliocytoma of the cerebellum). Homozygous deletion of Pten causes embryonic lethality in mice. To investigate function in the brain, we used Cre-loxP technology to selectively inactivate Pten in specific mouse neuronal populations. Loss of Pten resulted in progressive macrocephaly and seizures. Neurons lacking Pten expressed high levels of phosphorylated Akt and showed a progressive increase in soma size without evidence of abnormal proliferation. Cerebellar abnormalities closely resembled the histopathology of human Lhermitte-Duclos disease. These results indicate that Pten regulates neuronal size in vivo in a cell-autonomous manner and provide new insights into the etiology of Lhermitte-Duclos disease.
Insights
Loss of the PTEN gene in mice causes brain abnormalities like macrocephaly and seizures, mimicking human Lhermitte-Duclos disease. This study reveals PTEN regulates neuronal size, offering insights into related human neurological disorders.
Area of Science:
- Neuroscience
- Genetics
- Oncology
Background:
- Somatic PTEN gene inactivation is observed in various human cancers.
- Germline PTEN mutations lead to diverse developmental abnormalities, including neurological issues like macrocephaly and seizures.
- PTEN gene deletion is lethal in embryonic mice, highlighting its critical role.
Purpose of the Study:
- To investigate the function of the PTEN gene in the mammalian brain.
- To understand the cellular mechanisms underlying PTEN-related neurological disorders.
- To model human Lhermitte-Duclos disease in mice.
Main Methods:
- Utilized Cre-loxP technology for targeted Pten gene inactivation in specific mouse neuronal populations.
- Analyzed the resulting phenotypes, including brain size, seizure activity, and neuronal morphology.
- Examined molecular markers such as phosphorylated Akt levels.
Main Results:
- Selective Pten inactivation in mouse neurons led to progressive macrocephaly and seizures.
- Neurons lacking Pten exhibited increased soma size and elevated phosphorylated Akt levels, without abnormal proliferation.
- Cerebellar histopathology in affected mice closely resembled human Lhermitte-Duclos disease.
Conclusions:
- Pten plays a crucial role in regulating neuronal size in a cell-autonomous manner.
- This research provides valuable insights into the pathogenesis of Lhermitte-Duclos disease.
- The findings establish a mouse model for studying PTEN-related neurological disorders.
